Care Capital III LLC

This profile gathers the share dealings of Care Capital III LLC across 4 companies, led by Minerva Neurosciences, Inc., Agile Therapeutics Inc and NephroGenex, Inc. Between 14 February 2014 and 13 February 2018, the trades on record add up to 20 filings.

In open-market terms, that means 3 purchases worth €12.4M on one side and 8 sales worth €12.0M on the other. Taken together, the purchases exceed the sales by €412k. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Other entries cover 2 share grants.

In size, the median ticket on the buying side is €3.3M.

The newest entry dates from 15 February 2018: a share grant, in Vaxart, Inc. The most recent open-market purchase was published on 9 July 2014, 4,490 days ago. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. Section 16 rules allow two business days to file each Form 4. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.